<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>1380755</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Soler Roselló, A</dc:author>
<dc:author>Vila Barja, J</dc:author>
<dc:author>López Pacios, M A</dc:author>
<dc:author>Morote Robles, J</dc:author>
<dc:author>de Torres Mateos, J A</dc:author>
<dc:description xml:lang="en">Eight patients with prostate adenoma and high surgical risk were given leuprolide in depot. Prostate volume decreased by 44.7% after 3 months of treatment and by 58.9% at six months. Two of the 7 patients were resident vesical catheter carriers, 28% re-started spontaneous miction.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>1992 May </dc:date>
<dc:title xml:lang="es">Tratamiento médico de la hiperplasia prostática benigna en pacientes con alto riesgo quirúrgico.</dc:title>
<dc:title xml:lang="en">[Medical treatment of benign prostatic hyperplasia in patients with high surgical risk].</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
